BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11258148)

  • 1. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
    Wettergren A
    Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-like peptide-1, satiety and appetite control.
    Blundell JE; Naslund E
    Br J Nutr; 1999 Apr; 81(4):259-60. PubMed ID: 10999011
    [No Abstract]   [Full Text] [Related]  

  • 3. The glucagon-like peptides: a double-edged therapeutic sword?
    Perry T; Greig NH
    Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of GLP-1 in meal-taking.
    Hellström PM; Näslund E
    Appetite; 1999 Apr; 32(2):276. PubMed ID: 10097034
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.
    Stanley S; Wynne K; Bloom S
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G693-7. PubMed ID: 15068960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Miniglucagon: is the precursor a traitor to its family or a genius? ].
    Bataille D; Fontés G; Costes S; Longuet C; Dalle S
    Journ Annu Diabetol Hotel Dieu; 2004; ():139-49. PubMed ID: 15259312
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of rat glicentin on intestinal adaptation in small intestine-resected rats.
    Hirotani Y; Taki M; Kataoka K; Kurokawa N; Satoh T; Sasaki K; Yanaihara C; Luo WQ; Yanaihara N
    Ann N Y Acad Sci; 1998 Dec; 865():601-5. PubMed ID: 9928077
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucagon and GLP (glucagon-like peptide)].
    Matsuyama T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():246-51. PubMed ID: 12238055
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac metabolism as a target for the treatment of heart failure.
    Taegtmeyer H
    Circulation; 2004 Aug; 110(8):894-6. PubMed ID: 15326079
    [No Abstract]   [Full Text] [Related]  

  • 10. On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects.
    Holst JJ; Toft-Nielsen MB; Orskov C; Nauck M; Willms B
    Ann N Y Acad Sci; 1996 Dec; 805():729-36. PubMed ID: 8993469
    [No Abstract]   [Full Text] [Related]  

  • 11. [GLP-1 and the control of insulin secretion].
    Thorens B
    Journ Annu Diabetol Hotel Dieu; 1994; ():33-46. PubMed ID: 8051830
    [No Abstract]   [Full Text] [Related]  

  • 12. Central glucagon-like peptide-I in the control of feeding.
    Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR
    Biochem Soc Trans; 1996 May; 24(2):581-4. PubMed ID: 8736807
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.
    Fehmann HC; Göke R; Göke B
    Endocr Rev; 1995 Jun; 16(3):390-410. PubMed ID: 7671853
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucagon-like peptide 1--a new physiologic mediator of satiety?].
    Gallwitz B; Schmidt WE
    Z Gastroenterol; 1996 Nov; 34(11):775-7. PubMed ID: 9045540
    [No Abstract]   [Full Text] [Related]  

  • 16. The incretins--outdated terminology in man?
    Edwards CM; Bloom SR
    Diabetologia; 1999 Sep; 42(9):1148-9. PubMed ID: 10447529
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagon-like peptide 1 (GLP-1) and eating.
    Gutzwiller JP; Degen L; Heuss L; Beglinger C
    Physiol Behav; 2004 Aug; 82(1):17-9. PubMed ID: 15234584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
    Gromada J; Rorsman P
    Horm Metab Res; 2004; 36(11-12):822-9. PubMed ID: 15655714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
    D'Alessio DA; Vahl TP
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E882-90. PubMed ID: 15140755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon and its family revisited.
    Lefèbvre PJ
    Diabetes Care; 1995 May; 18(5):715-30. PubMed ID: 8586014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.